PTQ.V - Protech Home Medical Corp.

TSXV - TSXV Delayed Price. Currency in CAD
0.7600
+0.0100 (+1.33%)
As of 1:40PM EDT. Market open.
Stock chart is not supported by your current browser
Previous Close0.7500
Open0.7500
Bid0.7600 x 0
Ask0.7700 x 0
Day's Range0.7500 - 0.7600
52 Week Range0.5000 - 1.0700
Volume16,752
Avg. Volume168,183
Market Cap63.482M
Beta (3Y Monthly)3.56
PE Ratio (TTM)N/A
EPS (TTM)-0.0100
Earnings DateN/A
Forward Dividend & YieldN/A (N/A)
Ex-Dividend DateN/A
1y Target Est2.50
  • CNW Group22 days ago

    L'OCRCVM permet la reprise de la négociation - PTQ

    L'OCRCVM permet la reprise de la négociation - PTQ

  • CNW Group22 days ago

    IIROC Trading Resumption - PTQ

    IIROC Trading Resumption - PTQ

  • GlobeNewswire22 days ago

    Protech Home Medical Obtains Default Judgment Against Fraudster

    Protech Home Medical Corp. (“Protech” or the “Company”) (TSXV: ‎PTQ), a healthcare services company with operations in the United States, is pleased to report an update related to the cyberscam breach that the Company previously disclosed in a press release dated May 6, 2019. As a result of the proficient work and swift response of Company management and its global legal advisors, DLA Piper, the Company has successfully applied to the Hong Kong Court to freeze the perpetrator’s bank account in Hong Kong which contained approximately CAD$8.6 million of the CAD$9.2 million that was stolen. Earlier today, the Company obtained default judgment against the perpetrator, which is the first step in commencing enforcement and garnishee proceedings.

  • CNW Group22 days ago

    Suspension de la négociation par l'OCRCVM - PTQ

    Suspension de la négociation par l'OCRCVM - PTQ

  • CNW Group22 days ago

    IIROC Trading Halt - PTQ

    IIROC Trading Halt - PTQ

  • Thomson Reuters StreetEvents2 months ago

    Edited Transcript of PTQ.V earnings conference call or presentation 22-May-19 2:00pm GMT

    Q2 2019 Protech Home Medical Corp Earnings Call

  • GlobeNewswire2 months ago

    Protech Home Medical Reports Solid Second Quarter Fiscal 2019 Financial Results

    Protech Home Medical Corp. (the “Company”) (PTQ.V), a healthcare services company with operations in the U.S., today announced its second quarter financial results and operational highlights. Revenue for quarter was $21.9 million, an increase of 17% compared to the same quarter in 2018. Adjusted EBITDA for quarter was $4 million, an increase of 78% compared to the same quarter in 2018.

  • GlobeNewswire2 months ago

    Protech Home Medical Announces Date and Time for Quarterly Conference Call

    Protech Home Medical Corp. (the “Company”) (PTQ.V), a healthcare services company with operations in the U.S., today announced that it will host its Q2 F2019 Earnings Conference Call on Wednesday, May 22, 2019 at 10:00 a.m. EDT. The Company provides in-home monitoring and disease management services for patients in the United States healthcare market. It seeks to continue to expand its offerings to include the management of several chronic disease states focusing on patients with heart or pulmonary disease, sleep disorders, reduced mobility and other chronic health conditions.

  • GlobeNewswire2 months ago

    Protech Home Medical Corp Disclosure Regarding Cyberscam Incident

    The Company has notified the appropriate authorities including the Royal Canadian Mounted Police ‎‎(RCMP), the Canadian Centre for Cyber Security and local police in Canada, the Federal Bureau of ‎Investigation (FBI) in the United States, and the Hong Kong Police Force and Hong Kong Joint Financial ‎Intelligence Unit (JFIU). The Company has retained RoundTower Technologies LLC, a leading cybersecurity firm, which has ‎moved to close the breach. While the potential loss associated with this fraud is significant, the Company’s financial position and ‎operations are sound, and management is confident in its ability to continue to provide a high level of ‎service to its clients.

  • GlobeNewswire3 months ago

    Protech Announces Execution of an LOI to Acquire a Profitable Business in the Northeastern U.S.

    NOT FOR DISSEMINATION IN THE UNITED STATES OR FOR DISTRIBUTION TO U.S. NEWSWIRE SERVICES AND DOES NOT CONSTITUTE AN OFFER OF THE SECURITIES DESCRIBED HEREIN. CINCINNATI, April 17, 2019 (GLOBE NEWSWIRE) -- Protech Home Medical Corp. (“Protech” or the “Company”) (PTQ.V), a healthcare services company with operations in the United States, is pleased to announce that it has executed a non-binding letter of intent (LOI) to acquire a private company in the Northeastern United States. The target company is a leader in the respiratory home care services industry in the Northeastern United States.

  • Thomson Reuters StreetEvents3 months ago

    Edited Transcript of PTQ.V earnings conference call or presentation 2-Apr-19 2:00pm GMT

    Q2 2019 Protech Home Medical Corp Earnings Call

  • GlobeNewswire4 months ago

    Protech Home Medical Announces Redemption of 7.5% Non-Convertible Unsecured Subordinated Debentures

    Protech Home Medical Corp. (“Protech” or the “Company”) (PTQ.V), a healthcare services company with operations in the U.S., today announced that it is issuing a notice of redemption to holders of its 7.5% non-convertible unsecured subordinated debentures due December 31, 2019 (the “Debentures”), representing a redemption in full of all of the currently outstanding Debentures. The Debentures will be redeemed on April 30, 2019 (the “Redemption Date”), in accordance with their terms. The Debentures will be redeemed at a total redemption price of $1,040.00 plus accrued and unpaid interest of $24.79166667 up to but excluding the Redemption Date, both per $1,000 principal amount.

  • CNW Group4 months ago

    Protech Home Medical Engages Oak Hill Financial Inc. to Provide Investor Relations Services

    CINCINNATI, OH , March 14, 2019 /CNW/ - Protech Home Medical Corp. (PTQ.V) ("Protech" or the "Company") is pleased to announce that it has retained Oak Hill Financial Inc. (" Oak Hill ") to provide investor relations services to the Company in compliance with regulatory guidelines. Oak Hill is a Toronto -based firm which develops strategic platforms for its clients that are utilized to gain exposure and recognition to the capital markets. Oak Hill provides asset management, capital market and investor relations services.

  • GlobeNewswire4 months ago

    Protech Home Medical Announces Closing of $15 Million Bought Deal Offering

    Protech Home Medical Corp. (the "Company") (PTQ.V) is pleased to announce that it has completed its previously announced bought deal private placement of unsecured convertible debentures (the "Convertible Debentures") for gross proceeds of $15 million, including the full exercise of the underwriters' option (the "Offering"). The Offering was conducted by a syndicate of underwriters led by Beacon Securities Limited, and including Canaccord Genuity Corp. and Haywood Securities Inc. (collectively, the "Underwriters"). The Convertible Debentures bear interest from the date of closing at a rate of 8.0% per annum, payable semi-annually in arrears on the last day of June and December in each year and will mature on March 7, 2024 (the "Maturity Date").

  • GlobeNewswire5 months ago

    Protech Home Medical Releases Q1 2019 Results; Posts Revenue Growth of 17% and Adjusted EBITDA Growth of 186% Year Over Year

    Protech Home Medical Corp. (the “Company”) (PTQ.V), a healthcare services company with operations in the U.S., today announced its first quarter financial results and operational highlights. “We continue to achieve these superior financial results while also improving on all aspects of our business including an increase in the number of patients served and respirator resupply set-ups or deliveries.

  • CNW Group5 months ago

    Protech Home Medical Announces $13 Million Bought Deal Offering

    CINCINNATI, OH , Feb. 15, 2019 /CNW/ - Protech Home Medical Corp. (the "Company") (PTQ.V) is pleased to announce that it has entered into an agreement with Beacon Securities Limited ("Beacon" or the "Lead Underwriter"), on behalf of a syndicate of underwriters (the "Underwriters"), pursuant to which the Underwriters have agreed to purchase, on a bought deal basis, $13,000,000 aggregate principal amount of unsecured convertible debentures (the "Convertible Debentures") at a price of $1,000 per Convertible Debenture (the "Offering"). The Convertible Debentures will mature five years after the Closing Date (as defined below) (the "Maturity Date") and shall bear interest at a rate of 8.0% per annum from the date of issue, payable semi-annually in arrears on the last day of June and December in each year, commencing June 30, 2019 .

  • GlobeNewswire6 months ago

    Protech Home Medical Announces Record 11X Adjusted EBITDA Growth and Significant Operating Cash Flow Growth in Year End Audited Financials

    Protech Home Medical Corp. (the “Company”) (PTQ.V), a healthcare services company with operations in the U.S., today announced its financial results for the year ended September 30, 2018 and operational highlights. Revenue for the fourth quarter of $20.3 million, representing the largest revenue recorded for any one quarter of the fiscal year ended September 30, 2018. Adjusted EBITDA for the year of $12.6 million, compared to $1.0 million for the year ended September 30, 2017, an increase of over 1,100%.